Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Alemtuzumab by Sanofi for T-Cell Leukemia: Likelihood of Approval
Alemtuzumab is under clinical development by Sanofi and currently in Phase I for T-Cell Leukemia. According to GlobalData, Phase I...